Human papillomavirus, it's genes...and cancer vaccines.
Genital human papillomavirus (HPV) infection is causally linked to the development of cervical cancer, a leading cause of cancer-related mortality in women worldwide. Recent studies demonstrate the effectiveness of virus-like particle-based vaccines to induce neutralizing antibodies against HPV and prevent cervical intraepithelial neoplasia.
Steller
Michael A
MA
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Caritas St. Elizabeth's Medical Center and Tufts-New England Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA. michael_stellar@cchcs.org
D019496:Cancer Vaccines; D005260:Female; D006801:Humans; D027383:Papillomaviridae / Q000235:genetics / Q000276:immunology*; D030361:Papillomavirus Infections / Q000150:complications / Q000235:genetics / Q000276:immunology*; D053918:Papillomavirus Vaccines; D014412:Tumor Virus Infections / Q000150:complications / Q000235:genetics / Q000276:immunology*; D002583:Uterine Cervical Neoplasms / Q000209:etiology / Q000276:immunology* / Q000517:prevention & control* / Q000821:virology
D019496:Cancer Vaccines; D053918:Papillomavirus Vaccines